Prediction of Survival and Analysis of Prognostic Factors for Patients With Combined Hepatocellular Carcinoma and Cholangiocarcinoma: A Population-Based Study

被引:10
作者
Wang, Jitao [1 ,2 ]
Li, Zhi [3 ]
Liao, Yong [2 ]
Li, Jinlong [2 ]
Dong, Hui [1 ]
Peng, Hao [1 ]
Xu, Wenjing [1 ]
Fan, Zhe [1 ]
Gao, Fengxiao [2 ]
Liu, Chengyu [2 ]
Liu, Dengxiang [2 ]
Zhang, Yewei [1 ,4 ]
机构
[1] Southeast Univ, Sch Med, Nanjing, Peoples R China
[2] Xingtai Peoples Hosp, Xingtai Inst Canc Control, Xingtai, Peoples R China
[3] North China Healthcare Grp, Xingtai Gen Hosp, Dept Infect Management, Xingtai, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
combined hepatocellular carcinoma and cholangiocarcinoma; overall survival; nomogram; prognostic factors; population-based study; Surveillance Epidemiology and End Results database; CURATIVE RESECTION; TRANSPLANTATION; FEATURES; UPDATE;
D O I
10.3389/fonc.2021.686972
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Combined hepatocellular carcinoma and cholangiocarcinoma (CHC) is an uncommon subtype of primary liver cancer. Because of limited epidemiological data, prognostic risk factors and therapeutic strategies for patients with CHC tend to be individualized. This study aimed to identify independent prognostic factors and develop a nomogram-based model for predicting the overall survival (OS) of patients with CHC. Methods We recruited eligible individuals from the Surveillance, Epidemiology, and End Results (SEER) database between 2004 and 2015 and randomly divided them into the training or verification cohort. Univariate and multivariate analyses were performed to identify independent variables associated with OS. Based on multivariate analysis, the nomogram was established, and its prediction performance was evaluated using the consistency index (C-index) and calibration curve. Results In total, 271 patients with CHC were included in our study. The median OS was 14 months, and the 1-, 3-, and 5-year OS rates were 52.3%, 27.1%, and 23.3%, respectively. In the training cohort, multivariate analysis showed that the pathological grade (hazard ratio [HR], 1.26; 95% confidence interval [CI]: 0.96-1.66), TNM stage (HR, 1.21; 95% CI: 1.02 - 1.44), and surgery (HR, 0.26; 95% CI: 0.17 - 0.40) were independent indicators of OS. The nomogram-based model related C-indexes were 0.76 (95% CI: 0.72 - 0.81) and 0.72 (95% CI: 0.66 - 0.79) in the training and validation cohorts, respectively. The calibration of the nomogram showed good consistency of 1-, 3-, and 5-year OS rates between the actual observed survival and predicted survival in both cohorts. The TNM stage (HR, 1.23; 95% CI: 1.01 - 1.49), and M stage (HR, 1.87; 95% CI: 1.14 3.05) were risk factors in the surgical treatment group. Surgical resection and liver transplantation could significantly prolong the survival, with no statistical difference observed. Conclusions The pathological grade, TNM stage, and surgery were independent prognostic factors for patients with CHC. We developed a nomogram model, in the form of a static nomogram or an online calculator, for predicting the OS of patients with CHC, with a good predictive performance.
引用
收藏
页数:11
相关论文
共 34 条
[1]  
Beaufrère A, 2021, J HEPATOL, V74, P1212, DOI 10.1016/j.jhep.2021.01.035
[2]   NCCN Guidelines® Insights Hepatobiliary Cancers, Version 1.2017 Featured Updates to the NCCN Guidelines [J].
Benson, Al B., III ;
D'Angelica, Michael I. ;
Abbott, Daniel E. ;
Abrams, Thomas A. ;
Alberts, Steven R. ;
Saenz, Daniel Anaya ;
Are, Chandrakanth ;
Brown, Daniel B. ;
Chang, Daniel T. ;
Covey, Anne M. ;
Hawkins, William ;
Iyer, Renuka ;
Jacob, Rojymon ;
Karachristos, Andrea ;
Kelley, R. Kate ;
Kim, Robin ;
Palta, Manisha ;
Park, James O. ;
Sahai, Vaibhav ;
Schefter, Tracey ;
Schmidt, Carl ;
Sicklick, Jason K. ;
Singh, Gagandeep ;
Sohal, Davendra ;
Stein, Stacey ;
Tian, G. Gary ;
Vauthey, Jean-Nicolas ;
Venook, Alan P. ;
Zhu, Andrew X. ;
Hoffmann, Karin G. ;
Darlow, Susan .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (05) :563-573
[3]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[4]   An Update on Long-Term Outcome of Curative Hepatic Resection for Hepatocholangiocarcinoma [J].
Chok, Kenneth Siu-Ho ;
Ng, Kelvin K. C. ;
Cheung, Tan To ;
Yuen, Wai Key ;
Poon, Ronnie T. P. ;
Lo, Chung Mau ;
Fan, Sheung Tat .
WORLD JOURNAL OF SURGERY, 2009, 33 (09) :1916-1921
[5]   Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors [J].
Jones, Christopher M. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) :371-372
[6]   Combined Hepatocellular-Cholangiocarcinoma: A Population-Level Analysis of an Uncommon Primary Liver Tumor [J].
Garancini, Mattia ;
Goffredo, Paolo ;
Pagni, Fabio ;
Romano, Fabrizio ;
Roman, Sanziana ;
Sosa, Julie Ann ;
Giardini, Vittorio .
LIVER TRANSPLANTATION, 2014, 20 (08) :952-959
[7]  
Gera S, 2017, WORLD J HEPATOL, V9, P300, DOI 10.4254/wjh.v9.i6.300
[8]   Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma [J].
Groeschl, Ryan T. ;
Turaga, Kiran K. ;
Gamblin, T. Clark .
JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (06) :608-612
[9]   Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery [J].
He, Chaobin ;
Zhang, Yu ;
Cai, Zhiyuan ;
Lin, Xiaojun .
BMC CANCER, 2019, 19 (1)
[10]   The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study [J].
He, Chaobin ;
Mao, Yize ;
Wang, Jun ;
Song, Yunda ;
Huang, Xin ;
Lin, Xiaojun ;
Li, Shengping .
JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (07) :1239-1250